home / stock / kaly / kaly news


KALY News and Press, Kali Inc From 03/12/20

Stock Information

Company Name: Kali Inc
Stock Symbol: KALY
Market: OTC

Menu

KALY KALY Quote KALY Short KALY News KALY Articles KALY Message Board
Get KALY Alerts

News, Short Squeeze, Breakout and More Instantly...

KALY - PURA Acquisition of KALY CBD Confections On Track to Close Tomorrow

DALLAS , March 12, 2020 /PRNewswire/ -- Puration, Inc. (USOTC: PURA) and Kali-Extracts (USOTC: KALY) announced today that the two companies are on track to close the their previously announced CBD Confections deal tomorrow on Friday. The final milestone to closing PURA's acquisition ...

KALY - PURA and KALY Set to Close CBD Confections Deal One Week From Today

DALLAS , March 6, 2020 /PRNewswire/ -- Puration, Inc. (USOTC: PURA) and Kali-Extracts, Inc. (USOTC: KALY) announced today that the two companies plan to close the their previously announced CBD Confections deal next Friday, one week from today. PURA is acquiring KALY's CBD Confection...

KALY - PURA Makes Bid for Hemp4mula CBD Confections Backed by $5 Million Investment

DALLAS , Feb. 12, 2020 /PRNewswire/ -- Puration, Inc. (USOTC: PURA) today announced making a formal proposal to Kali-Extracts (USOTC: KALY) to acquire KALY's Hemp4mula CBD Infused Confections operation.  On Monday, earlier this week, PURA announced closing on a $5 million investmen...

KALY - KALY Announces $20 Million LOI to Fund Cannabis Biopharmaceutical Technology

DALLAS , Feb. 4, 2020 /PRNewswire/ -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ('KALY') today announced entering into letter of intent (LOI) under which KALY could receive a $20 million investment to fund its Cannabis Biopharmaceutical Technology. KALY has ...

KALY - KALY Previews Investment Commitment Into Its Cannabis Biopharmaceutical Technology

Dallas, Texas--(Newsfile Corp. - February 3, 2020) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY"), today previewed a Letter of Intent (LOI) executed with a third-party investor. The LOI details are anticipated to be released tomorrow. Management indicates ...

KALY - KALY Patented Cannabis Biotech $50 Million Valuation Supported By Analyst Assessment Of Cannabis Pharmaceuticals Driving $66 Billion Sector

Dallas, Texas--(Newsfile Corp. - January 31, 2020) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY") today pointed to a Grand View Research report on the legal marijuana market projecting the legal marijuana market to reach over $66 Billion in value by 2025...

KALY - KALY - Kali-Extracts Cannabis Biopharma Initiative Stands to Benefit From Upcoming Session of UN Commission on Narcotic Drugs

DALLAS , Jan. 30, 2020 /PRNewswire/ -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ("KALY") management today commented on the potential benefit the company could enjoy from the upcoming session in March of the United Nations Commission on Narcotic Drugs . ...

KALY - KALY- Kali-Extracts Proprietary CBD Extract Could Offer Coronavirus Relief

Dallas, Texas--(Newsfile Corp. - January 29, 2020) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY") today confirmed efforts to evaluate its proprietary CBD extract formulation as a treatment for coronavirus symptoms. KALY's proprietary CBD formulation has be...

KALY - KALY-Kali-Extracts RespRx Could Offer Treatment for Coronavirus Symptoms

DALLAS , Jan. 28, 2020 /PRNewswire/ -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ("KALY") today highlighted that its RespRx CBD formulation could offer treatment for coronavirus symptoms.  KALY's CBD formulation has been developed for the treatment o...

KALY - KALY- Kali-Extracts Anticipates Gross Margin Increase from Cannabis Biopharmaceutical Technology Consolidation

DALLAS , Jan. 27, 2020 /PRNewswire/ -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ("KALY") today announced an anticipated increase in gross margins from the consolidation of its business structure and focus on its Cannabis Biopharmaceutical Technology.  KA...

Previous 10 Next 10